361 related articles for article (PubMed ID: 31013360)
1. PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia.
Zong L; Zhang M; Wang W; Wan X; Yang J; Xiang Y
Histopathology; 2019 Sep; 75(3):421-430. PubMed ID: 31013360
[TBL] [Abstract][Full Text] [Related]
2. Analysis of PD-L1 expression in trophoblastic tissues and tumors.
Lu B; Teng X; Fu G; Bao L; Tang J; Shi H; Lu W; Lu Y
Hum Pathol; 2019 Feb; 84():202-212. PubMed ID: 30339966
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases.
Veras E; Kurman RJ; Wang TL; Shih IM
Int J Gynecol Pathol; 2017 Mar; 36(2):146-153. PubMed ID: 27362903
[TBL] [Abstract][Full Text] [Related]
4. Whole transcriptome analysis of gestational trophoblastic neoplasms reveals altered PI3K signaling pathway in epithelioid trophoblastic tumor.
Cho EJ; Chun SM; Park H; Sung CO; Kim KR
Gynecol Oncol; 2020 Apr; 157(1):151-160. PubMed ID: 31954539
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma.
Wang Y; Deng J; Wang L; Zhou T; Yang J; Tian Z; Yang J; Chen H; Tang X; Zhao S; Zhou L; Tong A; Xu J
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958683
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid Trophoblastic Tumors: Treatments, Outcomes, and Potential Therapeutic Targets.
Yang J; Zong L; Wang J; Wan X; Feng F; Xiang Y
J Cancer; 2019; 10(1):11-19. PubMed ID: 30662520
[No Abstract] [Full Text] [Related]
7. Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors.
Mo S; Zong L; Chen X; Ban X; Li M; Lu Z; Yu S; Chen J
Arch Pathol Lab Med; 2023 Feb; 147(2):193-201. PubMed ID: 35671167
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 in gestational trophoblastic disease: an antibody evaluation.
Hoeijmakers YM; Simons M; Bulten J; Gorris MAJ; Ottevanger PB; de Vries IJM; Sweep FCGJ
Acta Obstet Gynecol Scand; 2022 Sep; 101(9):1007-1016. PubMed ID: 35689468
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes.
Bolze PA; Patrier S; Massardier J; Hajri T; Abbas F; Schott AM; Allias F; Devouassoux-Shisheboran M; Freyer G; Golfier F; You B
Int J Gynecol Cancer; 2017 Mar; 27(3):554-561. PubMed ID: 28060141
[TBL] [Abstract][Full Text] [Related]
10. Expression of B7 family checkpoint proteins in cervical cancer.
Zong L; Gu Y; Zhou Y; Kong Y; Mo S; Yu S; Xiang Y; Chen J
Mod Pathol; 2022 Jun; 35(6):786-793. PubMed ID: 34848831
[TBL] [Abstract][Full Text] [Related]
11. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
[No Abstract] [Full Text] [Related]
12. Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia.
Cheng H; Zong L; Yu S; Chen J; Wan X; Xiang Y; Yang J
Pathol Oncol Res; 2023; 29():1610918. PubMed ID: 36875956
[No Abstract] [Full Text] [Related]
13. Expression and clinical significance of VISTA, B7-H3, and PD-L1 in glioma.
Wang LC; Wang YL; He B; Zheng YJ; Yu HC; Liu ZY; Fan RR; Zan X; Liang RC; Wu ZP; Tang X; Wang GQ; Xu JG; Zhou LX
Clin Immunol; 2022 Dec; 245():109178. PubMed ID: 36368642
[TBL] [Abstract][Full Text] [Related]
14. V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma.
Muller S; Victoria Lai W; Adusumilli PS; Desmeules P; Frosina D; Jungbluth A; Ni A; Eguchi T; Travis WD; Ladanyi M; Zauderer MG; Sauter JL
Mod Pathol; 2020 Feb; 33(2):303-311. PubMed ID: 31537897
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer.
Yang J; Tian Z; Gao H; Xiong F; Cao C; Yu J; Shi W; Zhan Q; Yang C
BMC Cancer; 2022 May; 22(1):584. PubMed ID: 35624419
[TBL] [Abstract][Full Text] [Related]
16. Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix.
Zong L; Zhang Q; Zhou Y; Kong Y; Yu S; Chen J; Zhang Y; Xiang Y
J Immunol Res; 2020; 2020():1283632. PubMed ID: 32322590
[TBL] [Abstract][Full Text] [Related]
17. Gestational trophoblastic neoplasia: Novelties and challenges.
Silva ALMD; Monteiro KDN; Sun SY; Borbely AU
Placenta; 2021 Dec; 116():38-42. PubMed ID: 33685753
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of gestational trophoblastic neoplasia: Identifying therapeutic targets.
McNally L; Wu S; Hodges K; Oberley M; Wallbillich JJ; Jones NL; Herzog TJ; Thaker PH; Secord AA; Huang M
Gynecol Oncol; 2024 Jan; 184():111-116. PubMed ID: 38301309
[TBL] [Abstract][Full Text] [Related]
19. Expression status of PD-L1 and B7-H3 in mesothelioma.
Matsumura E; Kajino K; Abe M; Ohtsuji N; Saeki H; Hlaing MT; Hino O
Pathol Int; 2020 Dec; 70(12):999-1008. PubMed ID: 33027549
[TBL] [Abstract][Full Text] [Related]
20. Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meningioma.
Deng J; Ma M; Wang D; Zhu H; Hua L; Sun S; Chen H; Cheng H; Qian ZR; Xie Q; Zhang T; Gong Y
World Neurosurg; 2020 Mar; 135():e12-e18. PubMed ID: 31629137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
